Skip to the main content.

Cell and Gene Blog Series: Part 6 - Future ATMP Manufacturing Paradigms

Cell and Gene Blog Series: Part 6 - Future ATMP Manufacturing Paradigms

Blog 6, the penultimate episode in this series, focuses upon how ATMPs are manufactured along with current trends. In this chapter, Dr Dave Seaward also peers into how equipment and consumables supporting this sector might evolve.

Driving excellence in aseptic fill-finish: Our strategic partnership with Stäubli Robotics

Driving excellence in aseptic fill-finish: Our strategic partnership with Stäubli Robotics

At 3P innovation, we engineer automation with purpose - solutions that don’t just meet the demands of aseptic manufacturing but redefine what’s...

Read More
Custom pharmaceutical extrusion: powering the next generation of drug delivery systems

Custom pharmaceutical extrusion: powering the next generation of drug delivery systems

Pharmaceutical extrusion is a critical enabler in the manufacture of advanced drug delivery systems, from long-acting injectables to solid implants....

Read More
Responding to cell & gene fill-finish and automation scale-up challenges

Responding to cell & gene fill-finish and automation scale-up challenges

Before delving into some technical details of cell and gene therapy manufacturing, it’s worth pausing to reflect on the human stories that drive this...

Read More